Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Neural Circuits|November 6, 2023
GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potentialRavinder Naik Dharavath, Celeste Pina-Leblanc, Victor M Tang, et al.
Revista Brasileira De Reumatologia|September 12, 2015
Recommendations for the treatment of Sjögren's syndromeValéria Valim, Virgínia Fernandes Moça Trevisani, Sandra Gofinet Pasoto, et al.
JAMA Psychiatry|October 30, 2024
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical TrialTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
Frontiers in Psychiatry|June 4, 2025
Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research programYuliya S Nikolova, Anthony C Ruocco, Daniel Felsky, et al.
Advances in Rheumatology (London, England)|February 11, 2025
Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren's disease by the Brazilian Society of RheumatologyFabiola Reis de Oliveira, Simone Appenzeller, Sandra Gofinet Pasoto, et al.
Human Vaccines & Immunotherapeutics|July 4, 2024
Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren's syndromeKetty Lysie Libardi Lira Machado, Ismael Artur da Costa-Rocha, Laura Gonçalves Rodrigues Aguiar, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 18, 2023
Neuroimaging and Biosample Collection in the Toronto Adolescent and Youth Cohort Study: Rationale, Methods, and Early DataErin W Dickie, Stephanie H Ameis, Isabelle Boileau, et al.
Scientific Reports|May 18, 2021
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccinationIsmael Artur da Costa-Rocha, Ketty Lysie Libardi Lira Machado, Ana Carolina Campi-Azevedo, et al.
Pageof 3